Quickly find detailed resource listings for a variety of Maryland community services.
..............................
CESAR FAX Special Series on Synthetic Cannabinoids
May 2013
Stay on top of the most recent research and survey results regarding synthetic cannabinoids with this compilation of CESAR FAX issues on the topic.
CESAR FAX 2012 Bound and Indexed Volume Now Available
January 2013
Have all of the 2012 CESAR FAX issues at your fingertips, indexed by issue number and subject area! To purchase a hard copy, please mail this form along with a purchase order or check for $10 to CESAR.
CESAR FAX Special Series on Buprenorphine Updated
February 2013
While research indicates that buprenorphine is an effective drug for treating opioid dependence, we feel that the potential for its nonmedical use and related unintended consequences may be going unnoticed. This series of publications on buprenorphine was designed to highlight several indicators of the increased availability, diversion, and misuse of buprenorphine.
CESAR Responds to NPR's Story on Buprenorphine
August 2012
CESAR’s Director was recently interviewed for NPR’s July 31st Planet Money episode, “The Anti-Addiction Pill That's Big Business For Drug Dealers.” A podcast of the episode and CESAR’s expanded comments about the segment are available here (sort comments by “oldest first” and CESAR’s is the fourth comment).
CESAR Employment Opportunity: PI-Level NIH Researcher
International Conference on Opioids
June 9-11, 2013
75th Annual College on Problems of Drug Dependence Meeting
June 15-20, 2013
National Conference on Addiction Disorders
September 21-25, 2013